Cardinal Health, the world's largest supplier of services to the
healthcare industry, is building its first tablet coating facility
to offer its pharmaceutical clients a range of innovative delivery
systems that target the oral...
Scientists have described the cellular structure of a protein that
plays a critical role in drug resistance, which may open up new
avenues for laboratory research that may result in the enhancement
of existing therapies for Cancer...
Cambridge Biostability Limited (CBL) has commissioned the world's
first commercial sterile spray dryer for childhood vaccines, in
which the £1 million (€1.5 million) facility will produce clinical
trial material providing a precursor...
The first single laboratory platform for 3D imaging and metrology
of microfluidic devices has been made available, which allows for
the characterisation of subsurface structure in transparent media
with submicron accuracy.
Patheon has resumed normal production of Omnicef antibiotic powder
after it voluntarily suspended production in September at it
facility in Carolina, Puerto Rico, due to a US Food and Drug
Administration (FDA) manufacturing warning.
A toxicology-on-a-chip tool, which can analyse drug candidates for
toxicity before they advance to pre-clinical stages, has taken one
step further towards commercialisation as the technology promises
to aid laboratory researchers...
SciGen are to establish a manufacturing facility in China in a
response to the growing demand for the Hepatitis B (HBV) vaccine
and insulin, which has reached epidemic proportions with 2 billion
people having become infected with...
GlaxoSmithKline (GSK) has positioned itself to dominate the US flu
vaccine market after it completed the acquisition of Canadian
vaccine company ID Biomedical for $1.7 billion (€1.15 billion) last
week.
Roche has responded to recent criticism that it was protecting its
avian-flu formula too closely by identifying 12 prospective
partners to increase the global production of Tamiflu.
Biovest International used the Cancer Research Institute's recent
meeting to debut its newest cell culture instrument, the
AutovaxID-C, which represents an advance in personalised medicine,
reducing the possibility of cross contamination,...
CombiMatrix Molecular Diagnostics (CMD) are to collaborate with the
University Of California (UCLA), on a gene-based melanoma
laboratory test, which if successful, could result in the
development of a clinical molecular test that...
According to a new report, the demand for worldwide drug packaging
is expected to reach new heights, predicting growth of 5.3 per cent
annually to $24.3 billion (€20 7 billion) in 2009, driven by aging
demographic patterns increasing...
As low-cost contract manufacturing organisations (CMO) in Asia are
becoming more attractive to drug companies, Western CMOs are having
to develop new business strategies in order to compete.
A new algorithm, which automatically selects molecule images for
crystallisation in Silico studies, is set to advance laboratory
studies by increasing the speed and power of methods for
determining biological structures at high resolution,...
After a two-year tug-of-war, the World Trade Organization (WTO) has
solidified a landmark agreement to allow poor nations to import
generic versions of patented drugs to treat serious diseases or
epidemics.
Baxa Corporation launches its medication validation system that
validates narcotic returns and identifies counterfeit medications.
The system also offers validation of medication to ensure the type
and strength of high-risk medications.
Escalating drug costs could be driven down by up to $20 billion a
year and dwindling drug pipelines improved if a newly-formed US
research group is successful.
Laboratory researchers believe that a recent discovery will prove
highly effective in stopping the progress of anthrax infection,
further developing reliable treatments to diagnose this killer
microorganism.
A new report suggests that up to 30 biopharmaceutical products
developed by UK companies using cell-based manufacturing techniques
could be approved by 2012, reinforcing the idea that
biopharmaceuticals are increasingly being seen...
An automated prescription verification process is proving a
valuable tool for the prevention of drug dispensing errors and is
now gaining acceptance within the US pharmacy industry.
Researchers have developed a new laboratory technique, which allows
them to change sequences within a DNA molecule. The tool is set to
have positive implications in DNA lab-based medical diagnosis and
nanobiotechnology.
Merck is to cut 7,000 jobs, close five factories and three research
facilities, as the US pharmaceutical company continues to suffer
from the devastating repercussions caused by its painkiller Vioxx
and the pending lawsuits.
Schott Pharmaceutical Packaging will be the first international
manufacturer of primary pharmaceutical glass packaging to establish
a production site in China, in a move that will increase supply to
Chinese injectable drug manufacturers...
SemBioSys Genetics has demonstrated bio-equivalence of a
plant-produced insulin, which if realised, could become a viable
alternative to meet the demand for insulin as the incidence of
diabetes increases worldwide.
The world's first commercial-scale continuous sonocrystallisation
system promises to revolutionise the way crystals are processed in
pharmaceutical manufacturing.
Isopak have launched a new semi automatic capsule-filling machine
that is designed to deal with non-lubricated substances intended
for clinical trials, and drug or product development work.
GenoID has announced a breakthrough in human papillomavirus (HPV)
testing with the first ever laboratory test kit that uses a
real-time polymerase chain reaction (real-time PCR) method to
detect all virus variants that cause cervical...
Avecia spin-off, Reaxa, has announced that Umicore has taken a 21
per cent stake in a move that underlines Reaxa's business strategy
in looking at joint R&D, new product development and toll
manufacturing agreements.
Chemical company Lanxess, release its third quarter results that
show restructuring strategy is bearing fruit, with sales up and the
reduction of net financial debt that is supported by strong growth
in the chemical industry.
Specialty chemical company Avecia featured prominently at the
recent CPhI Expo in Madrid, announcing investments and activity,
which hint at the business of custom synthesis of APIs and advanced
intermediates coming back into favour.
Catch-up legislation from the EU has swept away the handicap on
European generics companies, allowing them to research copycat
drugs before patent expiry.
Innovative laboratory technology that produces a sharper picture of
the nano-machine that translates genetic program into proteins
gives a unique insight into how some types of antibiotics work
leading to the design of better ones.
Pall Corporation has revealed a unique approach for speeding
vaccine production, which could provide a solution to the
potentially huge demand for vaccines by governments and
pharmaceutical manufacturers in response to the avian flu...
Coremed has introduced its proprietary drug-delivery platform
technology that improves absorption of certain proteins and
macromolecules such as insulin within the gastrointestinal tract.
Cook Pharmica will be the first contract manufacturer to offer live
webcam services, an innovation that will enable both customers and
regulatory agencies to view production as it occurs.
Foss has introduced the latest in its NIRSystems analyser range,
featuring the company's XDS near-infrared (NIR) technology, for
improved analytical performance in harsh industrial manufacturing
environments.
Proditec exhibited its new automatic visual tablet inspection
system at the recent CPhI, designed to provide the first
alternative to manual pharmaceutical tablet inspection for smaller
laboratories.
AssurX have launched a software process for document control, which
will enable pharmaceutical manufacturing companies to streamline
their approach to monitoring safety issues and overall quality
control efforts.
Millipore has launched a new reverse osmosis (type III) water
purification system, designed to meet the needs of laboratories
that only require up to 30 L/day of purified tap water.
GE Healthcare has recently launched a number of diverse and
transformational medical technologies aimed at improving
productivity across the pharmaceutical manufacturing sector.
Malvern Instruments and Leeds University have formed a long-term
partnership to launch 'IntelliSense,' - a programme that will help
to deliver the next generation of sensors and control solutions,
creating opportunities...
The first melatonergic antidepressant to offer a new approach to
the treatment of depression is just over the horizon after new data
demonstrated positive efficacy with marked improvements in sleep
with no effect on daytime vigilance.
In response to the increasing demand for high potency APIs,
Omnichem is increasing its Class V handling capabilities with an
expansion of their facility in Louvain-la-Neuve, Belgium.
Novasep Process launches its latest Supercritical Fluid
Chromatography unit, which aims to cut time and operating costs by
incorporating an automated CO2 recycling feature making it suitable
for purification process development, laboratory...
Researchers have put forward a unique process for 'cleaning'
volatile organic compounds - a process that could have considerable
importance to organic compounds that are used in the pharmaceutical
manufacturing process.
Sterling Biotech, India's largest gelatin producer, has struck a
deal with Gujarat Biotech (TGBL) to purchase its manufacturing unit
for Rs 55 cr ($12.3 million) in an all cash deal. Sterling's
acquisition brings it one...
Roche has launched what it claims is the first commercially
available instrument for high-throughput DNA sequencing, enabling
sequencing of genomes and long DNA sequences up to 100 x faster
than current Sanger-based methods.
Researchers are developing breakthrough diabetes drugs that use
modified forms of a naturally occurring molecule produced by the
body. The approach characterises the major investments by the
biopharmaceutical industry to develop and...
A new generation of portable, handheld radiation detectors that
could have a range of potential applications from disease diagnosis
is the target for researchers from the UK, who have been awarded
almost £1.2 million as part of a...